Top Tweets for #whyweekos
Presented at #ACC25 | #REALPEII: In a propensity-matched cohort of 1,465 PE patients treated with EKOS or FlowTriever, EKOS patients had lower rates of major bleeding within 7 days & readmissions within 30 days. Real-world evidence supports EKOS safety in #PE practice. #WhyWeEKOS
Proud to announce the 300th patient enrollment in #HIPEITHO! #HIPEITHO is the first of its kind RCT trial in #PE and continues to show BSC’s commitment to #EvidenceBasedMedicine. #EKOS #WhyWeEKOS
Have you seen the results from the largest real-world and near real-time dataset evaluating advanced #PE therapies? Learn more about #REALPE here: https://t.co/xBmKhbBfHK
#WhyWeEKOS #EvidenceBasedMedicine
The results are in from the largest real-world and near real-time data set evaluating advanced #PE therapies. View here: https://t.co/CBIslLTHci #Sponsored #REALPE #WhyWeEKOS #EvidenceBasedMedicine
LIVE | Reality Check: New Perspectives on Endovascular Strategies for #PE Treatment. Learn more about The REAL-PE Analysis: https://t.co/xBmKhbBNxi
#MythShattered #WhyWeEKOS #TCT2023
Alan recounts his journey through a #pulmonaryembolism and how the #EKOS™ Endovascular System revolutionized his recovery. Hear his full story: https://t.co/BSXKz2258I #PE #WhyWeEKOS #WorldThrombosisDay
#EKOS has excellent safety outcomes and is consistently proven, making it a first-line of #PE intervention. Learn more about how Dr. Bock uses EKOS as part of his toolkit to treat PE #WhyWeEKOS
Jeremy S. Bock, MD, (@JeremySBockMD) talks about his experience with ultrasound-facilitated catheter-directed thrombolysis using the EKOS™ Endovascular System to treat pulmonary embolism. | #Sponsored by @bostonsci https://t.co/nYTRNUftUM
Today we celebrate a milestone, 100K #PE patients have been treated with #EKOS. EKOS continues to be the most studied device in the PE space. With low lytic, low blood loss, and proven results, this is #WhyWeEKOS
67y/o SOB, dizziness, DOE, RV/LV 1.9; Pulse: 127, BP: 91/62. Two 12cm EKOS+ catheters, TPA: 1mg bolus in each followed by 2mg/hr for 1 hr. Next day RV/LV 0.9; DC home 24 hours after admission. Great results w/ Optalyse protocol & EKOS+. #WhyWeEKOS #EKOS #PE @bsc_pi @bsc_vascular
Presented at #VENOUS2023 1036 #PE patients analyzed for in-hosp mortality showed #EKOS demonstrated a significantly lower rate, at any lytic dose, compared to those treated with mechanical thrombectomy. #WhyWeEKOS #EvidenceBasedMedicine https://t.co/OZbUsduGAe
Ever see data that makes you think: Hmmmm? Presented at #ISET2023 911 #PE pts analyzed for Hosp LOS showed mechanical thrombectomy had a 51% longer hospital stay than #EKOS. #WhyWeEKOS #EvidenceBasedMedicine @drksterling
(1/13) EKOS Catheter Insertion Tweetorial.
@MustafaAhmedMD @MouhamedAmr1 @Skmcelwee
My cofellows @Dr_Almubarak @DocEBROhimi
@UABCardiology @UABCVI #WIN
I am thrilled to share that #EKOS+ has fully launched & delivers 50% more ultrasound power to resolve #PE clot burden more quickly & completely. #WhyWeEKOS #EvidenceBasedMedicine Learn more about EKOS+: https://t.co/fjysHFajeB
*Only available in the US currently
Congratulations to the team at the University Medical Center of the Johannes Gutenberg University of Mainz for enrolling the first #HIPEITHO patient in Germany! @uni_mainz_eng @bostonsci @bsc_pi @docmrjaff @krosenfieldMD @drandrewsharp @Erik_Klok_MD @fniainle #WhyWeEkos
“We were that close – just a day or so – from getting on an airplane, getting on a cruise. I wouldn’t have survived. There’s no way. And to have the kind of help available right here near our home meant the world to us.”
STORY: https://t.co/EcYjIAkEoO
#HIPEITHO #clinicaltrials
Congratulations to the team at @UZH_en for enrolling the first #HIPEITHO patient in Switzerland! #EvidenceBasedMedicine #WhyWeEkos @docmrjaff @bsc_pi @fniainle @drandrewsharp @Erik_Klok_MD @krosenfieldMD @bostonsci
Welcome to #HIPEITHO @Erik_Klok_MD and study team at @LUMC_Leiden! The first site to open in The Netherlands! We look forward to your first enrollment! @bostonsci @bsc_pi @docmrjaff @drandrewsharp @fniainle @krosenfieldMD #Ekos #WhyWeEkos #EvidencedBasedMedicine
Attention HI-PEITHO study teams! Check your email for our July Newsletter! This edition includes links to view the mobile app training & series of investigator meetings + a spotlight on Professor Irene Lang’s first enrollment at Vienna General Hospital! #HIPEITHO #EKOS #WhyWeEKOS
With the current global #contrastshortage, Dr. @AnasSafadi8 shares his contrast-free technique using CTA as a roadmap for #EKOS catheter placement for the treatment of #PE. Learn more in this 10-minute video: https://t.co/Yo3t8o6WGq #WhyWeEKOS
EKOS is a safe, repeatable and reliable treatment that dissolves thrombus quickly with low lytic, low blood loss and low trauma – resulting in proven long-term outcomes. #evidencebasedmedicine #whyweEKOS #pulmonaryembolism #ekostherapy #BSCEMEA https://t.co/OO1bXX5BFY
Last Seen Hashtags on Sotwe
leather_sofa
Seen from United States
madrehehijo
Seen from Guatemala
momsonn
Seen from Brazil
omegle() +filter:videos()
Seen from Turkey
momsonn() filter:native_video
Seen from United Kingdom
mephilver
Seen from Argentina
olderbrother
Seen from Turkey
Ecomar
Seen from United States
omegle
Seen from United States
MantoReal
Seen from United States
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.6M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.1M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.8M followers
Taylor Swift
@taylorswift13
83.8M followers
Lady Gaga
@ladygaga
75.3M followers
Virat Kohli
@imvkohli
73M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.1M followers
Bill Gates
@billgates
65M followers
Selena Gomez
@selenagomez
62.9M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers